Moderna Inc. MRNA (+ 2.70%) and International Business Machines Corp. IBM (-0.64%) on Thursday announced plans to work together to find technology to help “smarter COVID-19 vaccine management”. Technologies that the companies will explore include artificial intelligence, blockchain, and hybrid cloud. “Moderna is committed to working with a coalition of partners to increase education and awareness of the importance of vaccination in combating COVID-19,” said Michael Mullette, general manager of Moderna’s North American commercial division. “We look forward to working with IBM to use digital innovation to build connections between organizations, governments and individuals and build trust in COVID-19 vaccines.” Moderna stock rose 1.6% in midday trading and IBM stock fell 0.7% while the Dow Jones Industrial Average DJIA (+ 0.47%) rose 118 points, or 0.4%. Moderna currently has one of three COVID-19 vaccines that have been granted emergency approval by the Food and Drug Administration. The other vaccines come from Pfizer Inc. PFE (+ 0.95%) and BioNTech SE BNTX (+ 1.07%) and Johnson & Johnson JNJ (-0.66%).